Atherosclerotic injury of arterial wall in patients with chronic infections - Immunopathologic factors and risk of coronary heart disease;Miażdżycowe uszkodzenie tȩtnic u pacjentów z przewlekłymi zakażeniami - Mechanizmy immijnopatologiczne i ryzyko choroby wieńcowej

Polskie Archiwum Medycyny Wewnetrznej

Volumn 97, Issue 6, 1997, Pages 578-582

  Okopień, Bogusław ^a   Herman, Zbigniew Stanisław ^a  

^a Akademii Medycznej w Katowicach   (Poland)

Author keywords

Atherosclerosis; Chlamydia pneumonias; Coronary heart disease; Helicobacter pylori

Indexed keywords

CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; CORONARY ARTERY ATHEROSCLEROSIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; REVIEW; RISK FACTOR;

CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; CORONARY ARTERIOSCLEROSIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; RISK FACTORS;

EID: 2542525530     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Valtonen V.V.: Infection as a risk factor for infarction and atherosclerosis. Ann. Med., 1991, 23, 539.
2. Hajjar D.P., Fabricant C.G., Minick C.R., Fabricant J.: Virus-induced atherosclerosis. Am. J. Pathol., 1986, 122, 62.
3. Adam E., Metnick J.L., Probtsfield J.L. i wsp.: High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet, 1987, 11, 291.
4. Yamashiroya H.M., Ghosh L., Yang R., Robertson A.L.: Herpersviridae in coronary vessels and aorta of young trauma victims. Am. J. Pathol., 1988, 130, 71.
5. Thom D.H., Wang S.P., Grayston T. i wsp.: Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler. Thromb., 1991, 11, 547.
6. Patel P., Mendall M.A., Carrington D. i wsp.: Association of Helicobacter pylori and Chlamydia pneuumoniae infections with coronary heart disease and cardiovascular risk factors. Br. Med. J., 1995, 311, 711.
7. Mendall M.A., Goggin P.M., Molineaux N. i wsp.: Childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet, 1992, 339, 896.
8. Mendall M.A., Goggin P.M., Molineaux N. i wsp : Relation of Helicobacter pylon infection and coronary heart disease. Br. Heart J., 1994, 71, 437.
9. Whincup P.H., Mendall M.A., Perry I.J., Strachan D.P., Walker M.: Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men. Heart, 1996, 75, 568.
10. Śattila K.J., Nieminen M.S., Valtonen V. V. i wsp.: Association between dental health and acute myocardial infarction. Br. Med. J., 1989, 298, 779.
11. Schein W., Meryn S.: Helicobacter pylori and the mouth cavity - overview and perspectives. Wien Klin. Wochensehr, 1994, 106, 547.
12. Yarnell J W.G., Baker I.A., Sweetnam P.M. i wsp.: Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. Circulation, 1991, 83, 836.
13. Libby P., Hansson G.K.: Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab. Invest., 1991, 64, 5.
14. Konturek S.: Basic and clinical aspects of Helicobacter pylori. J. Physiol. Pharmacol., 1995, 46 suppl. 2, 4.
15. Siminiak T.I.: Neutrophil interactions with endothelium and platelets: possible role in the development of cardiovascular injury. Eur. Heart J., 1995, 16, 160.
16. Mendall M.A., Patel P., Ballam L., Strachan D., Northfield T.C.: C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study Br. Med. J., 1996, 312, 1061.
17. Muhlestein J., Hammond E., Carlquist J. i wsp.: Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic lesions versus other forms of cardiovascular disease. J. Am. Coll. Cardiol., 1996, 27, 1555.
18. Kuo C.C., Shor A., Campbell L.A., Fukushi H., Patton D.L., G Rayston J.T.: Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J. Infect. Dis., 1993, 167, 841.
19. Tipping P.G., Malliaros J., Holdsworth S.R. Procoagulant activity expression by macrophages from atheromatous vascular plaques. Atherosclerosis, 1989, 79, 237.
20. Puolakkainen M., Kuo C.C., Shor A., Wang S.P., Grayston J.T., Campbell L.A. Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty stroaks and fibrolipid plaques. J. Clin. Microbiol., 1993, 31, 2212.
21. Saikku P., Leinonen M., Mattila K. i wsp.: Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet, 1988, 11, 983.
22. Mlettinen H., Lehto S., Saikku P. i wsp.: Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland. Eur. Heart J., 1996, 17, 682.
23. Ross R.. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, 1993, 362, 801.
24. Przyklenk K., Kloner R.A.: 'Reperfusion injury' by oxygen-derived free radicals: effects of superoxide dismutase plus catalase, given at the time of reperfusion, on myocardial infarct size, contractile function, coronary microvasculature and regional myocardial blood flow. Circ. Res., 1989, 64, 86.
25. Opie L.: Reperfusion injury and its pharmacologic modification. Circulation, 1989, 4, 1049.
26. Niemela S., Kurttunen T., Korhonen T. i wsp.: Could Helicobacter pylori infection increase the tisk of coronary heart disease by modifying serum lipid concentrations? Heart, 1996, 75, 573.
27. Kaufmann S.: Heat shock proteins and the immune response. Immunol. Today, 1990, 11, 129.
28. Xu Q., Willeit J., Marosi M.: Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet, 1993, 341, 255.
29. Res P.C.M., Schaar C.G., Breedveld F.C. i wsp.: Synovial fluid T cell reactivity againts the 65 kD heat shock protein of mycobacteria in early chronic arthritis. Lancet, 1988, 10, 478.
30. Ivanyi L., Ivanyi J.: Elevated antibody levels to mycobacterial 65-kDa stress protein in patients with superficial candidiasis. J. Infect. Dis., 1990, 162, 519.
31. Gardinali M., Conciato L., Cafaro C., Agostoni A.: Complement system in coronary heart disease: a review. Immunopharmacol., 1995, 30, 105.
32. Dreyer W.J., Michael L.H., Nguyen T. i wsp.: Kinetics of C5a release in cardiac lymph of dogs experiencing coronary artery ischemia-reperfusion injury. Circ. Res., 1992, 71. 1518.
33. Kilgore K.S., Friedrichs G.S., Homeister J.W., Lucchesi B.R.. The complement system in myocardial ischemia/reperfusion injury. Cardiovasc. Res.. 1994, 28, 437.
34. Kowalski J., Pawlicki L., Kośmider M. i wsp.: Aktywacja dopelniacza w czasie zabiegu przezskórnej angioplastyki tȩtnicy wieńcowej. Kardiol. Pol., 1996, 45, 25.
35. Weisman H.F., Bartow T., Leppo M.K. i wsp.: Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post ischemic myocardial inflammation and necrosis. Science, 1990, 249, 146.
36. Beyersdorf F.J., Fuchs J., Eberhardt B., Stauder M., Satter P., Zimmer G,: Myocardial protection by 2-mercaptopropionyl-glycine during global ischemia in dogs. Arzneim. Forsch., 1989, 39, 46.
37. Howden C. W.: Clinical expressions of Helicobacter pylori infection. Am. J. Med., 1996, 100, 27S.